Macular Edema
📧 Sign up to get email alerts when something new happens for Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: VISUPRIME® Eye Drops [NA]
Clinical trial update noting the completion of a VISUPRIME Eye Drops study sponsored by VISUfarma SpA for several retinal diseases.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 3]
A Phase 3 study comparing KSI-301 with aflibercept in macular edema due to retinal vein occlusion has completed. Results were posted in June…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Bevacizumab and Retinal Vascular Occlusions [Phase 3]
A Phase 3 trial of bevacizumab for macular edema and retinal vascular occlusion has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome
A completed clinical study from Federico II University investigated radial peripapillary vessel density in Irvine-Gass syndrome (pseudophaki…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation [Phase 2]
Phase 2 trial evaluating topical nepafenac for macular thickening and edema after pan-retinal photocoagulation was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation [Phase 4]
A Phase 4 clinical trial comparing the timing of bevacizumab administration before versus after pattern panretinal photocoagulation in macul…
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Avastin for Post-photocoagulation Macular Edema [Phase 4]
A Phase 4 trial of bevacizumab (Avastin) for macular edema after photocoagulation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO [Phase 4]
A Phase 4 trial evaluating bevacizumab and triamcinolone for macular edema due to central retinal vein occlusion was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study [Phase 2]
Phase 2 AMOUR trial evaluating aflibercept for macular edema due to underlying retinitis pigmentosa has completed and results were posted in…
-
EMA approval · 2024-03-26EMA Authorised: Ximluci (ranibizumab) — STADA Arzneimittel AG
European Medicines Agency authorised Ximluci (ranibizumab) for indications including wet age-related macular degeneration, macular edema, an…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
A completed clinical trial evaluating VeriSee AMD for screening age-related macular degeneration; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion [Phase 3]
Phase 3 results evaluate Faricimab for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. The trial s…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion [Phase 3]
Phase 3 trial evaluating Faricimab for macular edema secondary to branch retinal vein occlusion has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema [Phase 4]
Phase 4 trial update examining long-term effectiveness and safety of intravitreal bevacizumab for retinal neovascularization and macular ede…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial [Phase 3]
Phase 3 trial comparing ranibizumab to intravitreal anti-inflammatory therapy in uveitis-associated macular edema has completed with results…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China [Phase 4]
Phase 4 clinical trial evaluating OZURDEX in macular edema due to retinal vein occlusion in China has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab [Phase 4]
Phase 4 trial evaluating aflibercept in patients with diabetic macular edema previously treated with ranibizumab or bevacizumab; study compl…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina [Phase 3]
Phase 3 study evaluating an updated dexamethasone intravitreal applicator for macular edema due to retinal diseases; study completed with re…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: An Innovative Chinese Herbal Formula for Macular Edema [Phase 2]
Phase 2 clinical trial update evaluating an innovative Chinese herbal formula for macular edema.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis [Phase 4]
Phase 4 trial assessing macular changes after intracameral moxifloxacin for endophthalmitis prevention has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF [Phase 2, Phase 3]
A multi-phase clinical trial evaluating Conbercept for refractory uveitic macular edema has been terminated after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion [Phase 3]
Phase 3 trial comparing brolucizumab to aflibercept in visual impairment from macular edema due to branch retinal vein occlusion; the study …
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion [Phase 3]
Phase 3 clinical trial update for conbercept ophthalmic injection in macular edema due to branch retinal vein occlusion completed.
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion [Phase 3]
Phase 3 trial update for Conbercept ophthalmic injection in macular edema due to central retinal vein occlusion has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 2]
Phase 2 trial of TLC399 (ProDex) in macular edema due to retinal vein occlusion completed with posted results.